Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (35)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Maeda, K.
Right arrow Articles by Okumura, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maeda, K.
Right arrow Articles by Okumura, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol 9, 993-1000, Copyright © 1997 by Oxford University Press


ARTICLES

Characterization of rat CD80 and CD86 by molecular cloning and mAb

K Maeda, T Sato, M Azuma, H Yagita and K Okumura
Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan.

The CD28/B7 pathway provides a critical co-stimulatory signal for T cell activation. In the present study, we cloned rat CD80 and CD86 cDNA from a HTLV-1-transformed rat T cell line, Lewis-S1, expressing a high level of CTLA-4-Ig binding proteins. The predicted CD80 and CD86 polypeptides were composed of 321 and 313 amino acids respectively, and exhibited features common to human and mouse B7 family proteins. Both CD80 and CD86 mRNAs were abundantly detected in HTLV-1-transformed rat T cell lines but not in a thymic lymphoma cell line. To further explore the function of rat CD80 and CD86, we generated cDNA transfectants and anti-rat CD80 (3H5) and anti-rat CD86 (24F) mAb. Rat CD80 or CD86 transfectants exhibited a potent co-stimulatory activity for rat T cell proliferation, which was blocked by 3H5 and 24F mAb respectively. 3H5 or 24F immunoprecipitated a 80-90 or 90-100 kDa surface protein from Lewis-S1 cells. HTLV-1-transformed rat T cell lines expressed high levels of both CD80 and CD86 as estimated by staining with 3H5 and 24F, which acted co-stimulatory for allogeneic T cell activation as estimated by blocking with 3H5 and 24F. These mAb will be useful for investigating the pathophysiological functions of CD80 and CD86 in transplantation, autoimmune diseases and HTLV-1-associated pathologies in the rat system.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Int ImmunolHome page
N. Takatsuka, A. Hasegawa, A. Takamori, Y. Shimizu, H. Kato, T. Ohashi, T. Amagasa, T. Masuda, and M. Kannagi
Induction of IL-10- and IFN-{gamma}-producing T-cell responses by autoreactive T-cells expressing human T-cell leukemia virus type I Tax
Int. Immunol., September 1, 2009; 21(9): 1089 - 1100.
[Abstract] [Full Text] [PDF]


Home page
Protein Eng Des SelHome page
R. Kolly, M. A. Thiel, T. Herrmann, and A. Pluckthun
Monovalent antibody scFv fragments selected to modulate T-cell activation by inhibition of CD86-CD28 interaction
Protein Eng. Des. Sel., February 8, 2007; (2007) gzl058v1.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Pyz, O. Naidenko, S. Miyake, T. Yamamura, I. Berberich, S. Cardell, M. Kronenberg, and T. Herrmann
The Complementarity Determining Region 2 of BV8S2 (Vbeta8.2) Contributes to Antigen Recognition by Rat Invariant NKT Cell TCR.
J. Immunol., June 15, 2006; 176(12): 7447 - 7455.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. Moghaddami, L. G. Cleland, and G. Mayrhofer
MHC II+ CD45+ cells from synovium-rich tissues of normal rats: phenotype, comparison with macrophage and dendritic cell lineages and differentiation into mature dendritic cells in vitro
Int. Immunol., August 1, 2005; 17(8): 1103 - 1115.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Nomura, T. Ohashi, K. Nishikawa, H. Nishitsuji, K. Kurihara, A. Hasegawa, R. A. Furuta, J.-i. Fujisawa, Y. Tanaka, S. Hanabuchi, et al.
Repression of Tax Expression Is Associated both with Resistance of Human T-Cell Leukemia Virus Type 1-Infected T Cells to Killing by Tax-Specific Cytotoxic T Lymphocytes and with Impaired Tumorigenicity in a Rat Model
J. Virol., April 15, 2004; 78(8): 3827 - 3836.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Yuan, A. D. Salama, V. Dong, I. Schmitt, N. Najafian, A. Chandraker, H. Akiba, H. Yagita, and M. H. Sayegh
The Role of the CD134-CD134 Ligand Costimulatory Pathway in Alloimmune Responses In Vivo
J. Immunol., March 15, 2003; 170(6): 2949 - 2955.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Ohashi, S. Hanabuchi, R. Suzuki, H. Kato, T. Masuda, and M. Kannagi
Correlation of Major Histocompatibility Complex Class I Downregulation with Resistance of Human T-Cell Leukemia Virus Type 1-Infected T Cells to Cytotoxic T-Lymphocyte Killing in a Rat Model
J. Virol., June 14, 2002; 76(14): 7010 - 7019.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. D. Mannie and M. R. Walker
Feedback activation of T-cell antigen-presenting cells during interactions with T-cell responders
J. Leukoc. Biol., August 1, 2001; 70(2): 252 - 260.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
T. Saiki, T. Ezaki, M. Ogawa, K. Maeda, H. Yagita, and K. Matsuno
In vivo roles of donor and host dendritic cells in allogeneic immune response: cluster formation with host proliferating T cells
J. Leukoc. Biol., May 1, 2001; 69(5): 705 - 712.
[Abstract] [Full Text]


Home page
Int ImmunolHome page
N. Torres-Nagel, B. Mehling, A.-F. LeRolle, E. Joly, and T. Hunig
Genetic control of peripheral TCRAV usage by representation in the preselection repertoire and MHC allele-specific overselection
Int. Immunol., January 1, 2001; 13(1): 63 - 73.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
T. Kawai, M. Seki, H. Watanabe, J. W. Eastcott, D. J. Smith, and M. A. Taubman
Th1 transmigration anergy: a new concept of endothelial cell-T cell regulatory interaction
Int. Immunol., June 1, 2000; 12(6): 937 - 948.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Kawai, R. Eisen-Lev, M. Seki, J. W. Eastcott, M. E. Wilson, and M. A. Taubman
Requirement of B7 Costimulation for Th1-Mediated Inflammatory Bone Resorption in Experimental Periodontal Disease
J. Immunol., February 15, 2000; 164(4): 2102 - 2109.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Hanabuchi, T. Ohashi, Y. Koya, H. Kato, F. Takemura, K. Hirokawa, T. Yoshiki, H. Yagita, K. Okumura, and M. Kannagi
Development of Human T-Cell Leukemia Virus Type 1-Transformed Tumors in Rats following Suppression of T-Cell Immunity by CD80 and CD86 Blockade
J. Virol., January 1, 2000; 74(1): 428 - 435.
[Abstract] [Full Text]


Home page
Int ImmunolHome page
T. Tamatani, K. Tezuka, and N. Hanzawa-Higuchi
AILIM/ICOS: a novel lymphocyte adhesion molecule
Int. Immunol., January 1, 2000; 12(1): 51 - 55.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. M. Patel, P. Y. Arnold, G. A. White, J. P. Nardella, and M. D. Mannie
Class II MHC/Peptide Complexes Are Released from APC and Are Acquired by T Cell Responders During Specific Antigen Recognition
J. Immunol., November 15, 1999; 163(10): 5201 - 5210.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.